Document Detail


Zoledronic acid in genitourinary cancer.
MedLine Citation:
PMID:  23615978     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Bone metastases are a common complication of advanced prostate cancer and while they are less common in non-prostate genitourinary (GU) malignances, they have been reported in up to 35 % of patients with advanced renal cell carcinoma and bladder cancer. Furthermore, they may occur in more than two-thirds of those patients with bladder cancer who develop distant metastases. In the absence of bone-targeted therapies, approximately 50 % of all patients with metastatic bone disease from GU cancers experience at least one skeletal-related event within their lifetime. Zoledronic acid is a bisphosphonate that has been shown to delay or prevent the development of skeletal complications in patients with bone metastases and reduce bone pain in these patients. Furthermore, zoledronic acid has also demonstrated the ability to prevent osteopenia, which may occur with the prolonged use of some pharmacological interventions in patients with cancer.
Authors:
M A Climent; U Anido; M J Méndez-Vidal; J Puente
Related Documents :
20113898 - Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?
23411388 - Progress in the implementation of nccn guidelines for distress management by member ins...
23378948 - Laparoscopic staging and surgical treatment of pancreatic cancer.
22985058 - Factors associated with the severity and improvement of fatigue in patients with advanc...
10854148 - Prospects for herpes-simplex-virus thymidine-kinase and cytokine gene transduction as i...
19889448 - Pathologic diagnosis and resection of suspicious thoracic metastases in patients with c...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-4-25
Journal Detail:
Title:  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico     Volume:  -     ISSN:  1699-3055     ISO Abbreviation:  Clin Transl Oncol     Publication Date:  2013 Apr 
Date Detail:
Created Date:  2013-4-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101247119     Medline TA:  Clin Transl Oncol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Servicio de Oncología Médica, Instituto Valenciano de Oncología (IVO), C/Beltrán Báguena, 8, 46009, Valencia, Spain, macliment@fivo.org.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Epigallocatechin-3-gallate promotes apoptosis and expression of the caspase 9a splice variant in PC3...
Next Document:  Ependymoma in children: molecular considerations and therapeutic insights.